-
1.
公开(公告)号:US20240279403A1
公开(公告)日:2024-08-22
申请号:US18565147
申请日:2023-04-28
IPC分类号: C08G81/00 , C08G65/337
CPC分类号: C08G81/00 , C08G65/337
摘要: An object is to provide a novel artificial slime-like polymer material having stability against an external solvent without changing the chemical composition of a main chain skeleton, a solvent, and the like constituting the polymer material and without impairing the viscosity and elasticity of the slime-like material.
It has been found that by controlling the number of branches, terminal connectivity, and concentration of polymer units constituting the polymer material, it is possible to provide a slime-like polymer material that induces liquid-liquid phase separation and thereby control solubility in external solvents.-
公开(公告)号:US20240294746A1
公开(公告)日:2024-09-05
申请号:US18565153
申请日:2023-04-28
IPC分类号: C08L51/08 , C08F8/42 , C08F283/06
CPC分类号: C08L51/08 , C08F8/42 , C08F283/06 , C08L2201/54 , C08L2205/025 , C08L2205/04
摘要: [Object]
An object of the present invention is to provide a novel artificial slime-like polymer material capable of controlling flow characteristics without changing a chemical composition such as a main chain skeleton or a solvent constituting the polymer material.
[Solution]
It is found that a slime-like polymer material in which liquid-liquid phase separation is induced can be provided and fluidity of the polymer material can be controlled by adding a polymer that does not react with a polymer unit serving as a basic skeleton constituting the polymer material in addition to the polymer unit.-
3.
公开(公告)号:US20220331439A1
公开(公告)日:2022-10-20
申请号:US17628676
申请日:2020-07-27
发明人: Kanjiro MIYATA , Beob Soo KIM , Shigehito OSAWA , Mitsuru NAITO , Hiroyuki CHAYA
摘要: A drug-polymer conjugate having thermoresponsiveness includes at least one drug conjugated to at least one end portion of at least one thermoresponsive polymer segment having a lower critical solution temperature. The drug-polymer conjugate is capable of forming a micellular aggregate in an aqueous medium at temperatures equal to or above the lower critical solution temperature. The drug-polymer conjugate or the micellular aggregate thereof may be administered to and absorbed in the lungs.
-
公开(公告)号:US20230414765A1
公开(公告)日:2023-12-28
申请号:US18463711
申请日:2023-09-08
申请人: AGC INC. , THE UNIVERSITY OF TOKYO , NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
发明人: Mihoko HARA , Rintaro HARA , Kanjiro MIYATA , Mitsuru NAITO , Takanori YOKOTA
CPC分类号: A61K47/595 , C08G69/48 , A61K47/60
摘要: A polymer represented by the following formula (I):
wherein each symbol is as described in the specification, is useful as a drug carrier in effectively delivering a drug to a target site.-
公开(公告)号:US20210346290A1
公开(公告)日:2021-11-11
申请号:US17251521
申请日:2019-06-13
发明人: Yasutaka ANRAKU , Kazunori KATAOKA , Shigeto FUKUSHIMA , Kanjiro MIYATA , Hyun Su MIN , Mitsuru NAITO
IPC分类号: A61K9/107 , A61K31/7088 , A61K47/34 , A61K9/00 , A61P3/08
摘要: The present invention provides a polyion complex micelle including an antisense oligonucleotide and a block copolymer of a cationic polymer and a PEG block having a number average molecular weight of 3 kDa to 10 kDa.
-
-
-
-